I am surprised to have to write on this topic; however, there appears to still be some confusion among a few authors who wish to submit their manuscript to the New Zealand Medical Journal (NZMJ) about whether ethics approval was required for their study.
Full article available to subscribers
I am surprised to have to write on this topic; however, there appears to still be some confusion among a few authors who wish to submit their manuscript to the New Zealand Medical Journal (NZMJ) about whether ethics approval was required for their study. The answer, if you wish to publish in the NZMJ, is that it usually is required, and this should be arranged before the study has been undertaken.
The recommendations of the International Committee of Medical Journal Editors (ICMJE) states, “All investigators should ensure that the planning, conduct, and reporting of human research are in accordance with the Helsinki Declaration as revised in 2013. All authors should seek approval to conduct research from an independent local, regional or national review body (e.g., ethics committee, institutional review board), and be prepared to provide documentation when requested by editors.”1
The main point of confusion among those submitting to the NZMJ seems to be research undertaken with quality assurance data. Collection of quality assurance data for quality assurance projects are exempt from the need to obtain ethics approval in New Zealand;2 however, the secondary use of this data for research does need ethics approval to be published.
Quality assurance projects are undertaken primarily for the purpose of evaluating current or slightly new practices, and the primary aim is to inform current care in a localised scope, rather than generate generalisable information. These data are meant for those involved in the patient care pathway, not those outside of it. Full discussion about this can be obtained here: https://neac.health.govt.nz/national-ethical-standards/part-two/18-quality-improvement
However, when data are acquired for quality assurances projects and are then subsequently used for research and published in the NZMJ, then ethics approval is required. When quality assurance data are published as research in a journal, they are available to those outside of the patient care pathway, and in the case of the NZMJ the data are then available to the public as we have an open access policy. As such, we require ethical approval to be obtained.
If you wish to use quality assurance data in research and publish it in the NZMJ, please obtain ethical approval before you undertake your research.
Frank Frizelle: Editor-in-Chief NZMJ; Professor of Surgery; Department of Surgery, University of Otago Christchurch, New Zealand.
Nil.
1) International Committee of Medical Journal Editors. Protection of Research Participants [Internet]. [cited 2024 Aug 30]. Available from: https://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html
2) Health and Disability Ethics Committees. General frequently asked questions [Internet]. 2024 Feb 22 [cited 2024 Aug 30]. Available from: https://ethics.health.govt.nz/frequently-asked-questions
3) National Ethics Advisory Committee. 18. Quality improvement [Internet]. 2021 Apr 27 [cited 2024 Aug 30]. https://neac.health.govt.nz/national-ethical-standards/part-two/18-quality-improvement
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz